Stay updated on Dara-Thal-Dex in Relapse Myeloma Clinical Trial

Sign up to get notified when there's something new on the Dara-Thal-Dex in Relapse Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dara-Thal-Dex in Relapse Myeloma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The clinical trial record for daratumumab, thalidomide, and dexamethasone in relapsed or refractory myeloma is displayed, with study design, participant criteria, outcome measures, contacts, and locations.
    Difference
    54%
    Check dated 2026-11-09T13:36:00.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.8.0 instead of v3.7.2. The page continues to show a 403 Forbidden error rather than the study record.
    Difference
    0.2%
    Check dated 2026-11-02T13:42:06.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A sitewide banner announces NIH website transition updates and says the terms “Super Intelligence” and “Artificial Intelligence” may both appear during the transition.
    Difference
    1%
    Check dated 2026-10-26T15:37:07.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.1 to v3.7.2, while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-19T15:31:27.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The site revision marker on the 403 Forbidden page changed from v3.7.0 to v3.7.1; no study-record content changed.
    Difference
    0.2%
    Check dated 2026-10-12T15:24:50.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page, replacing the previous study content with a standard access-denied layout. This indicates restricted access to the content rather than a substantive update to the page's study information.
    Difference
    19%
    Check dated 2026-09-21T21:50:35.000Z thumbnail image

Stay in the know with updates to Dara-Thal-Dex in Relapse Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dara-Thal-Dex in Relapse Myeloma Clinical Trial page.